Compounds of formula I or pharmaceutically acceptable salts thereof:
wherein R
1
, R
2
, R
3
, R
4
, and R
5
and are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
Nucleotide monomers, polynucleotides, methods of making each, and methods of deprotecting each, are disclosed.
本文公开了核苷酸单体、多核苷酸、每种核苷酸的制造方法以及每种核苷酸的脱保护方法。
Monomer Compositions for the Synthesis of RNA, Methods of Synthesis, and Methods of Deprotection
申请人:Agilent Technologies, Inc.
公开号:EP2567964A2
公开(公告)日:2013-03-13
2'-O protected nucleotide monomers for the synthesis of RNA.
用于合成 RNA 的 2'-O 保护核苷酸单体。
The Role of Neighboring Groups in Replacement Reactions. XXII. Competition between o-MeO-5 and Ar<sub>1</sub>-3 Participation in Solvolysis of o-Methoxyneophyl Tolunesulfonate<sup>1,2</sup>
作者:R. Heck、J. Corse、E. Grunwald、S. Winstein
DOI:10.1021/ja01569a076
日期:1957.6
TROUPEL, MICHEL;ROBIN, YVES;GUITTON, PASCALE;CHAUSSARD, JACQUES
作者:TROUPEL, MICHEL、ROBIN, YVES、GUITTON, PASCALE、CHAUSSARD, JACQUES